Member Info for HelloSanDiego

https://www.google.com/search?q=nhs+cost+of+ambrisentan

You're not going to mention the fact it would still be a few hundred percent up on its price when they suspended it?

T.Rat - "BT is a nano-optofluidic chip coated with Optimers and Aptamers and read by laser. Not mass spectrometry... "

That's what I'm unclear about, because mass spectrometry means 'read by lasers'.

So if Microtox's nano-optofluidic chip can do the job, why do we need Microsaic's mass-spectrometers? And if we've got a commercial agreement in place, who are we selling them to and why?

Does Microtox BT use Microsaic's technology to do the actual analysis then?

When we were told about the scanners that the breathalyser cartridges would be put into, is it essentially this mass-spectrometer that Microsaic will be supplying?

You're right. I thought they said it would be published by the 27th March. But I just checked and it says "end of March".

The last we heard from them the AIM admission document was expected to be published this week.

So if that's no longer the case we should at least hear an update by Friday on when it's now expected.

CityTTrader - "£3-5 is the minimum level I expect on good news. It is nowhere near what I expect on takeover."

Take a look at what happened to Motif Bio in February 2019 when the share price dropped 75% in a day.

After successful P3 trials for a new antibiotic they applied for FDA approval. The FDA then requested further data (that hadn't been required previously) and the share price plummetted from 40p down to 7p, before eventually falling to half a penny. Your valuation seems to be based on the belief that at each subsequent stage, success here is guaranteed. But the reality is far from it.

If P3 is successful I think it will take us up to about £3.50 before it slides back down to around £2.80, and if a takeover bid came in at that point £6 or £8 would be very generous.

For the additional costs involved does this offer any benefits over the lateral flow tests?

Being a breath test and avoiding the need to swab inside your mouth and nose is a big improvement, but are there any others?

Littleaddy - "I may be reading it wrong."

Sorry it was my mistake, I misread your comment. But anyway, I think AIM must be satisfied with the progress they're making if they've granted a delay to the cancellation.

https://www.nbcnews.com/id/wbna16614865

There's no hoax. It really is a deadly chemical and the evidence supports that fact.

I've heard that some vaccines contain dihydrogen monoxide and there's evidence people have died from that.

I don't trust doctors unless I'm ill or injured - then they're the first people I turn to.

Retireby40 - "I expect the water monitoring to generate revenue a lot more quickly than BT snd that’s fine with me."

Again, I disagree. By far the biggest share price movements here have been caused by news about the breathalyser.

Retireby40 - "if the test/s are effective they’ll want it"

That's another assumption that people on here are taking as fact. But in reality they might be looking for other solutions. There are no guarantees they'll even be willing to sit down and talk to Deepverge if it hasn't already been arranged and confirmed.

Retireby40 - "Whether we’re in talks with the cruise cos is immaterial."

I disagree. I think it would be very significant if it has been confirmed.

My only sources of information are this board, RNSs and Proactive interviews. So if anybody knows where I can find more information about that I would appreciate it.

Glebewhite - "we know we are in talks with the cruise industry"

Has that been confirmed anywhere or just hinted at?

"watch from 7 min 30 sec onward, immediately after the army he clearly says ramping is after data readout."

No he doesn't. There's no mention of ramping anything. His words are "there's a whole army of people working on the manufacturing side to make sure we can make enough drug to satisfy market demand".

Nothing about that suggests that they're waiting until they have the data before beginning the manufacturing they've already committed to. But if you're saying that it will eventually need scaling up again to take it beyond the 100,000/month target they've already set, I agree.

He said in the January 28th interview that "there's a whole army of people working on the maufacturing side". He also said in the middle of last year that the product has long lead times.

So even if they aren't producing 100,000 doses a month yet, they're obviously working on having it ready so it's available when it's needed.

Am I right in thinking that the Phase 2 trial was extended to include more participants (820 altogether) and the Phase 3 continues as soon as that one is completed?

Is there any news on when Synairgen is due to complete the Activ-2 trial?

Hewhodares1 - "Never has and never will be a vaccine for [bubonic plague] as it's treated simply with common antibiotics! That's embarrassing!"

The CDC says plague vaccines have been in use since the 19th century...
https://www.cdc.gov/mmwr/preview/mmwrhtml/00041848.htm

...but the WHO doesn't recommend it unless you're in a high-risk groups (such as laboratory personnel who are constantly exposed to the risk of contamination, and health care workers).
https://www.who.int/news-room/fact-sheets/detail/plague

Also, none have been approved in Europe or the US as their effectiveness has never been measured precisely. I assume that's because there are only a few dozen cases a year worldwide, which would make testing a vaccine impossible.

LordGibil, all the people I know who have had it are around a similar age, fit and healthy and they described pretty much the same thing, i.e. tight chest and breathlessness when moving. It was after a few days of symptoms starting that they gradually began to ease and they were back to normal within two weeks of the symptoms starting. So for what it's worth, it sounds like a typical case and she'll hopefully begin to see an improvement soon. Obviously she should speak to a doctor immediately if she hasn't already done so, or if her condition worsens.